20 LATEST RESOURCES (28 INDEXED)
×
Real-World Effectiveness of Antipsychotic Doses for Relapse Prevention in Patients with First-Episode Schizophrenia in Finland: A Nationwide, Register-Based Cohort Study · February 2022
Abstracts
Lancet Psychiatry
×
Efficacy and Safety of Balovaptan for Socialisation and Communication Difficulties in Autistic Adults in North America and Europe: A Phase 3, Randomised, Placebo-Controlled Trial · February 2022
Abstracts
Lancet Psychiatry
×
Safety and Efficacy of Agomelatine in Children and Adolescents with Major Depressive Disorder Receiving Psychosocial Counselling: A Double-Blind, Randomised, Controlled, Phase 3 Trial in Nine Countries · December 2021
Abstracts
Lancet Psychiatry
×
Pimavanserin for Negative Symptoms of Schizophrenia: Results from the Advance Phase 2 Randomised, Placebo-Controlled Trial in North America and Europe · November 2021
Abstracts
Lancet Psychiatry
×
Associations between Plasma Fatty Acid Concentrations and Schizophrenia: A Two-Sample Mendelian Randomisation Study · November 2021
Abstracts
Lancet Psychiatry
×
Antipsychotic Use and Risk of Breast Cancer in Women with Schizophrenia: A Nationwide Nested Case-Control Study in Finland · August 2021
Abstracts
Lancet Psychiatry
×
Risk of Serious Medical Events in Patients with Depression Treated with Electroconvulsive Therapy: A Propensity Score-Matched, Retrospective Cohort Study · July 2021
Abstracts
Lancet Psychiatry
×
Standard versus Reduced Dose of Antipsychotics for Relapse Prevention in Multi-Episode Schizophrenia: A Systematic Review and Meta-Analysis of Randomised Controlled Trials · June 2021
Abstracts
Lancet Psychiatry
×
Combining Behavioral Harm-Reduction Treatment and Extended-Release Naltrexone for People Experiencing Homelessness and Alcohol Use Disorder in the USA: A Randomised Clinical Trial · March 2021
Abstracts
Lancet Psychiatry
×
Amisulpride, Aripiprazole, and Olanzapine in Patients with Schizophrenia-Spectrum Disorders (BeSt InTro): A Pragmatic, Rater-Blind, Semi-Randomised Trial · October 2020
Abstracts
Lancet Psychiatry
×
Effectiveness of Digital Psychological Interventions for Mental Health Problems in Low-Income and Middle-Income Countries: A Systematic Review and Meta-Analysis · August 2020
Abstracts
Lancet Psychiatry
×
Multisystemic Therapy versus Management as Usual in the Treatment of Adolescent Antisocial Behaviour (START): 5-Year Follow-Up of a Pragmatic, Randomised, Controlled, Superiority Trial · April 2020
Abstracts
Lancet Psychiatry
×
Delivering the Thinking Healthy Programme for Perinatal Depression through Peers: An Individually Randomised Controlled Trial in India · February 2019
Abstracts
Lancet Psychiatry
×
Delivering the Thinking Healthy Programme for Perinatal Depression through Volunteer Peers: A Cluster Randomised Controlled Trial in Pakistan · January 2019
Abstracts
Lancet Psychiatry
×
Amisulpride and Olanzapine Followed by Open-Label Treatment with Clozapine in First-Episode Schizophrenia and Schizophreniform Disorder (OPTiMiSE): A Three-Phase Switching Study · August 2018
Abstracts
Lancet Psychiatry
×
Feedback-Informed Treatment versus Usual Psychological Treatment for Depression and Anxiety: A Multisite, Open-Label, Cluster Randomised Controlled Trial · June 2018
Abstracts
Lancet Psychiatry
×
Long-Term Effects of Discontinuation from Antipsychotic Maintenance Following First-Episode Schizophrenia and Related Disorders: A 10 Year Follow-Up of a Randomised, Double-Blind Trial · March 2018
Abstracts
Lancet Psychiatry
×
Does Depression Treatment Improve the Survival of Depressed Patients with Cancer? A Long-Term Follow-Up of Participants in the SMaRT Oncology-2 and 3 Trials · March 2018
Abstracts
Lancet Psychiatry
×
Electroconvulsive Therapy and Risk of Dementia in Patients with Affective Disorders: A Cohort Study · March 2018
Abstracts
Lancet Psychiatry